...
首页> 外文期刊>Pain and therapy. >A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental Pain
【24h】

A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental Pain

机译:与布洛芬酸的随机,双盲,安慰剂对照试验与布洛芬酸进行急性术后牙痛

获取原文

摘要

IntroductionIbuprofen acid is poorly soluble in the stomach, thus reaching maximum plasma levels at approximately 90?min post-dose. Ibuprofen lysinate has been developed to accelerate absorption of ibuprofen to shorten the time to analgesic efficacy. This study compared analgesic efficacy and onset of effect of a single dose of ibuprofen lysinate or ibuprofen acid in patients undergoing third molar extraction.MethodsRandomized, double-blind, placebo-controlled, multi-center, parallel-group single-dose study. Adults (18–60?years) undergoing extraction of?≥?1 third molar were randomized 2:2:1 to ibuprofen lysinate, ibuprofen acid, or placebo postoperatively. Pain relief (PAR, 5-point scale, 0?=?none to 4?=?complete pain relief) and pain intensity (PI, 100?mm visual analog scale) were assessed between 15 and 360?min post-dose. The primary endpoint was the weighted sum of PAR scores at 6?h (TOTPAR). Time to onset of effect, global assessment of efficacy, and adverse events were also assessed.ResultsOverall, 351 patients received ibuprofen lysinate ( N =?141), ibuprofen acid ( N =?139), or placebo ( N =?71). Both active treatments significantly reduced pain compared with placebo, from 15?min post-dose to 6?h (TOTPAR: ibuprofen lysinate: 19.57; ibuprofen acid: 19.96; placebo: 8.27). Ibuprofen lysinate was significantly more effective than placebo, but non-inferior to ibuprofen acid, at providing pain relief over 6?h. There was no significant difference between ibuprofen lysinate and ibuprofen acid for onset of analgesia. Both ibuprofen formulations were well tolerated; all adverse events were mild to moderate and considered unrelated to treatment.ConclusionsA single dose of ibuprofen lysinate is non-inferior to ibuprofen acid in terms of analgesic efficacy, onset of action, and tolerability in patients who have recently undergone dental surgery.Trial RegistrationEudraCT No. 2006-006942-33.Plain Language SummaryPlain language summary available for this article.
机译:引入芽孢杆酸可溶于胃中差,从而达到剂量后约90Ω·分钟的最大血浆水平。已经开发了布洛芬裂解肽,以加速布洛芬的吸收,缩短镇痛效果的时间。本研究比较镇痛疗效和一剂布洛芬溶解素或布洛芬酸在接受第三摩尔萃取的患者中的效果的衰退。方法,双盲,安慰剂控制,多中心,并联单剂量研究。成年人(18-60?年)接受提取的Δ≥13摩尔,术后2:2:1至布洛芬酸酯,布洛芬酸或安慰剂术后。疼痛缓解(PAR,5分,0?=?NONE 4?=?完全疼痛缓解)和疼痛强度(PI,100?MM视觉模拟量表)在15到360次后剂量的后剂量。主要终点是6?H(Totpar)的加权总和分数。还评估了效果,全球疗效评估和不良事件的时间,也评估了351名患者,接受布洛芬溶解素(n =β141),布洛芬酸(n =α139),或安慰剂(n =Δ71)。与安慰剂相比,疼痛显着降低了疼痛,从15?min后剂量至6?h(Totpar:布洛芬溶解素:19.57;布洛芬酸:19.96;安慰剂:8.27)。布洛芬裂解肽比安慰剂更有效,但非逊皮酸不逊色于6℃以上提供疼痛缓解。布洛芬透素与布洛芬酸在镇痛发作中没有显着差异。布洛芬配方均耐受良好;所有不良事件均为温和至中等,并且被认为与治疗无关。结论单剂量的布洛芬裂解素在镇痛效果,发作的镇痛疗效,作用发作和患者的耐受性,对牙科手术的患者进行单剂量.TRIAD RegistalyRact no 。2006-006942-33.PLAIN语言SummaryPlain语言摘要可用于本文。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号